LTGO Earnings Latigo Biotherapeutics, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Chart & overview → Latest filing
Quarterly results
EPS
Reported EPS history
1–2 of 2
| Q2 2026 | 2026-06-30 | -27.59 | 2026-09-03 | 10-Q |
| Q2 2025 | 2025-06-30 | -36.52 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.